Comprehensive Market Analysis Report: Global Bioresorbable Medical Materials Market (2026-2036)
1. Executive Summary
The global bioresorbable medical materials market represents a revolutionary and high-growth segment within advanced biomaterials, focused on polymers and composites designed to safely degrade and be absorbed by the body after fulfilling their temporary therapeutic function. These materials are fundamental to the development of next-generation medical implants, tissue engineering scaffolds, and advanced drug delivery systems. This report provides a refined analysis of market status and forecast from 2026 to 2036, evaluating market size, key material suppliers, polymer segmentation, and regional dynamics. Growth is propelled by the paradigm shift towards transient medical devices that eliminate long-term implant complications, drive tissue regeneration, and enable personalized therapeutic release profiles.
2. Market Overview
-
Market Valuation: The global bioresorbable medical materials market is projected to experience robust growth from 2026 to 2036, reaching a substantial market value by the end of the forecast period, supported by a high Compound Annual Growth Rate (CAGR).
-
Base Year: 2025
-
Forecast Period: 2026 - 2036
-
Key Drivers: Rising demand for minimally invasive and patient-friendly medical solutions, strong growth in regenerative medicine and tissue engineering, increasing applications in advanced drug delivery, and the clinical success of bioresorbable vascular scaffolds (BVS), stents, and orthopedic fixation devices.
-
Primary Challenges: Complex and costly manufacturing processes, stringent regulatory pathways requiring comprehensive degradation and biocompatibility data, managing the inflammatory response to degradation by-products, and achieving precise, predictable degradation kinetics matched to healing timelines.
3. Key Market Players
The landscape consists of specialized polymer science companies, diversified chemical giants, and biomedical-focused manufacturers.
-
Leading Polymer & Material Science Specialists:
-
Evonik Industries AG – A global leader in biomedical polymers, offering a broad portfolio under its RESOMER® brand (PLA, PLGA, PCL, and copolymers).
-
Corbion N.V. – A major producer of high-purity lactic acid and polylactic acid (PLA), serving as a critical feedstock and material supplier.
-
Poly-Med, Inc. – A US-based developer and manufacturer of a wide array of bioresorbable polymers and medical devices.
-
DSM Biomedical (part of Darinor) – Provider of biomedical materials including bioresorbable polymers for various applications.
-
-
Diversified Chemical & Healthcare Companies:
-
Mitsui Chemicals, Inc. – Active in biomaterial development, including bioresorbable polymers.
-
Ashland Global Holdings Inc. – Supplies specialty polymers for pharmaceutical and medical applications.
-
Merck KGaA (through its MilliporeSigma division) – Supplier of high-purity bioresorbable polymers for R&D and GMP production.
-
-
Specialized Device & Fabrication Companies: KLS Martin Group (specializes in resorbable craniomaxillofacial implants), Osteotec Ltd., Bioretec Ltd., Gunze Limited.
4. Market Segmentation Analysis
4.1 By Polymer Type
-
Polylactic Acid (PLA) and its Stereoisomers (PLLA, PDLA): The largest volume segment. Known for good mechanical strength and tunable degradation (months to years). Widely used in orthopedic fixation, sutures, and meshes.
-
Polyglycolic Acid (PGA): Fast-degrading (weeks to months), high strength. Often used in sutures and combined in copolymers to modulate degradation rates.
-
Poly(lactic-co-glycolic acid) (PLGA): The most versatile and widely researched copolymer. Degradation rate is precisely tunable by altering the LA:GA ratio. Dominant in drug delivery systems (microspheres, implants) and tissue engineering scaffolds.
-
Polycaprolactone (PCL): Slow-degrading (years), highly elastic and biocompatible. Used in long-term implants, drug delivery devices, and as a component in hybrid scaffolds.
-
Polysaccharides & Other Natural Polymers: Includes Chitosan, Hyaluronic Acid, Alginate. Excel in biocompatibility and cell interaction. Growing segment for hydrogel-based drug delivery and soft tissue engineering.
4.2 By Application
-
Orthopedics: Largest application segment. Includes screws, pins, plates, anchors, and meniscal repair devices for sports medicine and trauma. Eliminates the need for a second removal surgery.
-
Drug Delivery: High-growth segment. Includes biodegradable microspheres, nanoparticles, implants, and injectable depots for controlled, long-term release of drugs (e.g., cancer therapeutics, hormones, antibiotics).
-
Tissue Engineering & Regeneration: Critical for 3D scaffolds that provide temporary structure for cell growth and are gradually replaced by natural tissue (e.g., bone grafts, cartilage, vascular grafts).
-
Sutures & Wound Care: Established application for synthetic (PGA, PLA) and natural (chitosan) resorbable sutures and hemostats.
4.3 By Form
-
Filaments & Fibers: For sutures, meshes, and 3D printing of scaffolds.
-
Pellets & Resins: Raw material for injection molding, extrusion, or machining into implants.
-
Microspheres/Nanoparticles: For drug delivery and as injectable scaffolds.
-
3D-Printed/Sintered Porous Scaffolds: Customized, complex architectures for tissue engineering.
5. Regional Analysis
-
North America: Largest and most advanced market, driven by a strong medical device R&D ecosystem, high healthcare expenditure, favorable reimbursement for advanced technologies, and leading academic research.
-
Europe: Mature market with a robust regulatory framework (MDR) and significant research activity. Strong presence of key material suppliers (Evonik, Corbion, DSM).
-
Asia-Pacific: Fastest-growing regional market. Growth is fueled by increasing healthcare investments, rising medical tourism, growing domestic manufacturing of medical devices, and expanding research capabilities, particularly in Japan, China, and South Korea.
-
Latin America, Middle East & Africa: Emerging markets where adoption is currently focused on established applications like sutures, with gradual uptake of advanced orthopedic and drug delivery devices.
6. Porter’s Five Forces Analysis
-
Threat of New Entrants: Low to Moderate. Very high barriers include complex polymer synthesis and purification expertise, stringent regulatory requirements for medical-grade materials, significant capital investment, and established relationships between incumbents and major medical device OEMs.
-
Bargaining Power of Suppliers: Low for basic monomers (lactic acid, glycolide) but High for specialty intermediates and proprietary copolymer technologies. Suppliers of advanced fabrication equipment (e.g., for microspheres, electrospinning) hold moderate power.
-
Bargaining Power of Buyers: High. Buyers are large medical device and pharmaceutical companies that demand high quality, consistency, regulatory support, and often engage in long-term partnership agreements, exerting significant price and performance pressure.
-
Threat of Substitutes: Medium. Includes permanent implants (metals, non-resorbable polymers), non-degradable drug delivery systems, and alternative treatment modalities. The unique value proposition of transient devices limits direct substitution.
-
Industry Rivalry: Moderate to High. Competition is based on polymer purity, consistency, degradation profile libraries, technical support, intellectual property, and the ability to co-develop custom materials with device makers.
7. SWOT Analysis
-
Strengths: Enables transformative medical device concepts (no permanent foreign body), supports the body's natural healing and regeneration processes, eliminates secondary removal surgeries, and allows for sophisticated controlled drug release.
-
Weaknesses: Higher cost than permanent materials, complex manufacturing and sterilization processes, potential for variable inflammatory response, and degradation kinetics that must be meticulously matched to the clinical application.
-
Opportunities: Explosion in personalized medicine and 3D-printed patient-specific implants, growth in biologics delivery requiring advanced formulations, expansion into new therapeutic areas (cardiovascular, neurology), and development of "smart" materials with triggered degradation.
-
Threats: Regulatory setbacks from high-profile device failures (e.g., first-generation BVS), competition from improved permanent materials, and challenges in scaling up novel material production cost-effectively.
8. Trend Analysis
-
Multi-Material and Composite Systems: Development of polymer-ceramic composites (e.g., PLGA/β-TCP) for bone regeneration or polymer-drug conjugates with enhanced therapeutic profiles.
-
4D Printing & Smart Degradation: Materials engineered to change shape or degrade in response to specific biological triggers (pH, enzymes, temperature), enabling highly localized therapy.
-
Focus on By-Product Management: Designing polymers that degrade into completely benign, naturally metabolized by-products to minimize inflammatory response and ensure long-term safety.
-
Convergence with Cell Therapy & Biologics: Materials serving as advanced delivery vehicles or protective matrices for live cells, proteins, and genes in regenerative medicine.
9. Market Drivers & Challenges
-
Drivers:
-
The clinical and economic benefits of avoiding implant removal surgeries and long-term complications (e.g., infection, stress shielding in orthopedics).
-
Unprecedented growth in the fields of targeted and sustained drug delivery, particularly for high-value biologics.
-
Government and private funding fueling regenerative medicine research.
-
Continuous innovation in polymer science and additive manufacturing (3D printing) unlocking new device designs.
-
-
Challenges:
-
Achieving and demonstrating predictable, reproducible degradation rates across diverse patient populations and anatomical sites.
-
Balancing initial mechanical strength requirements with appropriate degradation speed for load-bearing applications.
-
Navigating the complex and evolving regulatory pathway for combination products (device + drug/biologic).
-
Managing the high cost of goods, especially for complex copolymers and composite materials.
-
10. Value Chain Analysis
-
Monomer Synthesis & Purification: Production of high-purity cyclic dimers (lactide, glycolide) and other monomers from renewable or petrochemical sources.
-
Polymerization & Advanced Copolymer Synthesis: Controlled ring-opening polymerization (ROP) or polycondensation to create polymers with specific molecular weights, crystallinity, and copolymer ratios.
-
Formulation & Compounding: Creating blends, composites, or masterbatches with drugs, ceramics, or processing aids.
-
Regulatory & Quality Assurance: Extensive characterization (GPC, DSC, NMR) and biocompatibility testing (ISO 10993) to meet FDA/EMA standards for implantable materials.
-
Medical Device Manufacturing (OEMs): Processing materials via extrusion, injection molding, electrospinning, or 3D printing into final devices (screws, scaffolds, microspheres).
-
Sterilization & Packaging: Using methods compatible with polymers (ethylene oxide, gamma radiation) that do not induce premature degradation.
-
Clinical Use & In-Vivo Degradation: Implantation and the controlled, safe resorption of the material by hydrolysis and metabolic clearance.
11. Strategic Recommendations for Stakeholders
-
For Material Suppliers: Invest in R&D for next-generation polymers with enhanced properties (toughness, elasticity, tunable degradation). Develop expansive application-specific data packages (degradation profiles, mechanical properties over time) to accelerate customer device development. Offer comprehensive regulatory support services. Pursue strategic vertical integration or partnerships with key OEMs in high-growth areas like drug delivery.
-
For Investors: Focus on companies with proprietary polymer chemistry, strong IP portfolios, and established partnerships with tier-1 medical device companies. Companies enabling personalized medicine through 3D printing or novel drug delivery platforms are particularly attractive. Evaluate the scalability of production processes.
-
For Medical Device OEMs: Engage material suppliers early in the R&D process to co-develop solutions tailored to specific mechanical and degradation needs. Invest in robust preclinical testing to fully characterize the degradation and healing response. Clearly communicate the long-term patient benefits of resorbable technology to clinicians and payers.
-
For Regulators: Develop adaptive regulatory frameworks that encourage innovation in this complex space while ensuring patient safety. Provide clear guidance on the necessary testing paradigms for demonstrating safety and efficacy of novel resorbable materials and combination products.
-
For Healthcare Providers & Payers: Recognize the long-term value proposition of bioresorbable devices in reducing complication rates, eliminating secondary procedures, and improving patient quality of life. Support outcome-based reimbursement models that capture these total lifecycle benefits.
Table of Contents
Global Bioresorbable Medical Material Market Research Report 2026
1 Industry Overview of Bioresorbable Medical Material
1.1 Definition and Specifications of Bioresorbable Medical Material
1.1.1 Definition of Bioresorbable Medical Material
1.1.2 Specifications of Bioresorbable Medical Material
1.2 Classification of Bioresorbable Medical Material
1.2.1 Polylactic Acid (PLA)
1.2.2 Polyglycolic Acid (PGA)
1.2.3 Polysaccharides
1.2.4 Polycaprolactone (PCL)
1.2.5 PLGA
1.3 Applications of Bioresorbable Medical Material
1.3.1 Drug Delivery
1.3.2 Orthopedics
1.3.3 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India
2 Manufacturing Cost Structure Analysis of Bioresorbable Medical Material
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Bioresorbable Medical Material
2.3 Manufacturing Process Analysis of Bioresorbable Medical Material
2.4 Industry Chain Structure of Bioresorbable Medical Material
3 Technical Data and Manufacturing Plants Analysis of Bioresorbable Medical Material
3.1 Capacity and Commercial Production Date of Global Bioresorbable Medical Material Major Manufacturers
3.2 Manufacturing Plants Distribution of Global Bioresorbable Medical Material Major Manufacturers
3.3 R&D Status and Technology Source of Global Bioresorbable Medical Material Major Manufacturers
3.4 Raw Materials Sources Analysis of Global Bioresorbable Medical Material Major Manufacturers
4 Global Bioresorbable Medical Material Overall Market Overview
4.1 E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 E Global Bioresorbable Medical Material Capacity and Growth Rate Analysis
4.2.2 Bioresorbable Medical Material Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 E Global Bioresorbable Medical Material Sales and Growth Rate Analysis
4.3.2 Bioresorbable Medical Material Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 E Global Bioresorbable Medical Material Sales Price
4.4.2 Bioresorbable Medical Material Sales Price Analysis (Company Segment)
5 Bioresorbable Medical Material Regional Market Analysis
5.1 North America Bioresorbable Medical Material Market Analysis
5.1.1 North America Bioresorbable Medical Material Market Overview
5.1.2 North America E Bioresorbable Medical Material Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America E Bioresorbable Medical Material Sales Price Analysis
5.1.4 North America Bioresorbable Medical Material Market Share Analysis
5.2 Europe Bioresorbable Medical Material Market Analysis
5.2.1 Europe Bioresorbable Medical Material Market Overview
5.2.2 Europe E Bioresorbable Medical Material Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe E Bioresorbable Medical Material Sales Price Analysis
5.2.4 Europe Bioresorbable Medical Material Market Share Analysis
5.3 China Bioresorbable Medical Material Market Analysis
5.3.1 China Bioresorbable Medical Material Market Overview
5.3.2 China E Bioresorbable Medical Material Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China E Bioresorbable Medical Material Sales Price Analysis
5.3.4 China Bioresorbable Medical Material Market Share Analysis
5.4 Japan Bioresorbable Medical Material Market Analysis
5.4.1 Japan Bioresorbable Medical Material Market Overview
5.4.2 Japan E Bioresorbable Medical Material Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan E Bioresorbable Medical Material Sales Price Analysis
5.4.4 Japan Bioresorbable Medical Material Market Share Analysis
5.5 Southeast Asia Bioresorbable Medical Material Market Analysis
5.5.1 Southeast Asia Bioresorbable Medical Material Market Overview
5.5.2 Southeast Asia E Bioresorbable Medical Material Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia E Bioresorbable Medical Material Sales Price Analysis
5.5.4 Southeast Asia Bioresorbable Medical Material Market Share Analysis
5.6 India Bioresorbable Medical Material Market Analysis
5.6.1 India Bioresorbable Medical Material Market Overview
5.6.2 India E Bioresorbable Medical Material Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India E Bioresorbable Medical Material Sales Price Analysis
5.6.4 India Bioresorbable Medical Material Market Share Analysis
6 Global E Bioresorbable Medical Material Segment Market Analysis (by Type)
6.1 Global E Bioresorbable Medical Material Sales by Type
6.2 Different Types of Bioresorbable Medical Material Product Interview Price Analysis
6.3 Different Types of Bioresorbable Medical Material Product Driving Factors Analysis
6.3.1 Polylactic Acid (PLA) Growth Driving Factor Analysis
6.3.2 Polyglycolic Acid (PGA) Growth Driving Factor Analysis
6.3.3 Polysaccharides Growth Driving Factor Analysis
6.3.4 Polycaprolactone (PCL) Growth Driving Factor Analysis
6.3.5 PLGA Growth Driving Factor Analysis
7 Global E Bioresorbable Medical Material Segment Market Analysis (by Application)
7.1 Global E Bioresorbable Medical Material Consumption by Application
7.2 Different Application of Bioresorbable Medical Material Product Interview Price Analysis
7.3 Different Application of Bioresorbable Medical Material Product Driving Factors Analysis
7.3.1 Drug Delivery of Bioresorbable Medical Material Growth Driving Factor Analysis
7.3.2 Orthopedics of Bioresorbable Medical Material Growth Driving Factor Analysis
7.3.3 Others of Bioresorbable Medical Material Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Bioresorbable Medical Material
8.1 Evonik
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Evonik Bioresorbable Medical Material Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Evonik Bioresorbable Medical Material Business Region Distribution Analysis
8.2 Corbion
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Corbion Bioresorbable Medical Material Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Corbion Bioresorbable Medical Material Business Region Distribution Analysis
8.3 DSM
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 DSM Bioresorbable Medical Material Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 DSM Bioresorbable Medical Material Business Region Distribution Analysis
8.4 Mitsui Chemicals
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Mitsui Chemicals Bioresorbable Medical Material Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Mitsui Chemicals Bioresorbable Medical Material Business Region Distribution Analysis
8.5 PCAS
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 PCAS Bioresorbable Medical Material Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 PCAS Bioresorbable Medical Material Business Region Distribution Analysis
8.6 Poly-Med
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Poly-Med Bioresorbable Medical Material Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Poly-Med Bioresorbable Medical Material Business Region Distribution Analysis
8.7 KLS Martin
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 KLS Martin Bioresorbable Medical Material Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 KLS Martin Bioresorbable Medical Material Business Region Distribution Analysis
9 Development Trend of Analysis of Bioresorbable Medical Material Market
9.1 Global Bioresorbable Medical Material Market Trend Analysis
9.1.1 Global 2018-2025 Bioresorbable Medical Material Market Size (Volume and Value) Forecast
9.1.2 Global 2018-2025 Bioresorbable Medical Material Sales Price Forecast
9.2 Bioresorbable Medical Material Regional Market Trend
9.2.1 North America 2018-2025 Bioresorbable Medical Material Consumption Forecast
9.2.2 Europe 2018-2025 Bioresorbable Medical Material Consumption Forecast
9.2.3 China 2018-2025 Bioresorbable Medical Material Consumption Forecast
9.2.4 Japan 2018-2025 Bioresorbable Medical Material Consumption Forecast
9.2.5 Southeast Asia 2018-2025 Bioresorbable Medical Material Consumption Forecast
9.2.6 India 2018-2025 Bioresorbable Medical Material Consumption Forecast
9.3 Bioresorbable Medical Material Market Trend (Product Type)
9.4 Bioresorbable Medical Material Market Trend (Application)
10 Bioresorbable Medical Material Marketing Type Analysis
10.1 Bioresorbable Medical Material Regional Marketing Type Analysis
10.2 Bioresorbable Medical Material International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Bioresorbable Medical Material by Region
10.4 Bioresorbable Medical Material Supply Chain Analysis
11 Consumers Analysis of Bioresorbable Medical Material
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Bioresorbable Medical Material Market Professional Survey Report
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Bioresorbable Medical Material
Table Product Specifications of Bioresorbable Medical Material
Table Classification of Bioresorbable Medical Material
Figure Global Production Market Share of Bioresorbable Medical Material by Type in
Figure Polylactic Acid (PLA) Picture
Table Major Manufacturers of Polylactic Acid (PLA)
Figure Polyglycolic Acid (PGA) Picture
Table Major Manufacturers of Polyglycolic Acid (PGA)
Figure Polysaccharides Picture
Table Major Manufacturers of Polysaccharides
Figure Polycaprolactone (PCL) Picture
Table Major Manufacturers of Polycaprolactone (PCL)
Figure PLGA Picture
Table Major Manufacturers of PLGA
Table Applications of Bioresorbable Medical Material
Figure Global Consumption Volume Market Share of Bioresorbable Medical Material by Application in
Figure Drug Delivery Examples
Table Major Consumers in Drug Delivery
Figure Orthopedics Examples
Table Major Consumers in Orthopedics
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Bioresorbable Medical Material by Regions
Figure North America Bioresorbable Medical Material Market Size (Million USD) (2013-2025)
Figure Europe Bioresorbable Medical Material Market Size (Million USD) (2013-2025)
Figure China Bioresorbable Medical Material Market Size (Million USD) (2013-2025)
Figure Japan Bioresorbable Medical Material Market Size (Million USD) (2013-2025)
Figure Southeast Asia Bioresorbable Medical Material Market Size (Million USD) (2013-2025)
Figure India Bioresorbable Medical Material Market Size (Million USD) (2013-2025)
Table Bioresorbable Medical Material Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Bioresorbable Medical Material in
Figure Manufacturing Process Analysis of Bioresorbable Medical Material
Figure Industry Chain Structure of Bioresorbable Medical Material
Table Capacity and Commercial Production Date of Global Bioresorbable Medical Material Major Manufacturers
Table Manufacturing Plants Distribution of Global Bioresorbable Medical Material Major Manufacturers
Table R&D Status and Technology Source of Global Bioresorbable Medical Material Major Manufacturers
Table Raw Materials Sources Analysis of Global Bioresorbable Medical Material Major Manufacturers
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Bioresorbable Medical Material E
Figure Global E Bioresorbable Medical Material Market Size (Volume) and Growth Rate
Figure Global E Bioresorbable Medical Material Market Size (Value) and Growth Rate
Table E Global Bioresorbable Medical Material Capacity and Growth Rate
Table Global Bioresorbable Medical Material Capacity (K MT) List (Company Segment)
Table E Global Bioresorbable Medical Material Sales (K MT) and Growth Rate
Table Global Bioresorbable Medical Material Sales (K MT) List (Company Segment)
Table E Global Bioresorbable Medical Material Sales Price (USD/MT)
Table Global Bioresorbable Medical Material Sales Price (USD/MT) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K MT) of Bioresorbable Medical Material E
Figure North America E Bioresorbable Medical Material Sales Price (USD/MT)
Figure North America Bioresorbable Medical Material Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K MT) of Bioresorbable Medical Material E
Figure Europe E Bioresorbable Medical Material Sales Price (USD/MT)
Figure Europe Bioresorbable Medical Material Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K MT) of Bioresorbable Medical Material E
Figure China E Bioresorbable Medical Material Sales Price (USD/MT)
Figure China Bioresorbable Medical Material Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K MT) of Bioresorbable Medical Material E
Figure Japan E Bioresorbable Medical Material Sales Price (USD/MT)
Figure Japan Bioresorbable Medical Material Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K MT) of Bioresorbable Medical Material E
Figure Southeast Asia E Bioresorbable Medical Material Sales Price (USD/MT)
Figure Southeast Asia Bioresorbable Medical Material Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K MT) of Bioresorbable Medical Material E
Figure India E Bioresorbable Medical Material Sales Price (USD/MT)
Figure India Bioresorbable Medical Material Sales Market Share
Table Global E Bioresorbable Medical Material Sales (K MT) by Type
Table Different Types Bioresorbable Medical Material Product Interview Price
Table Global E Bioresorbable Medical Material Sales (K MT) by Application
Table Different Application Bioresorbable Medical Material Product Interview Price
Table Evonik Information List
Table Product Overview
Table Evonik Bioresorbable Medical Material Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure Evonik Bioresorbable Medical Material Business Region Distribution
Table Corbion Information List
Table Product Overview
Table Corbion Bioresorbable Medical Material Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure Corbion Bioresorbable Medical Material Business Region Distribution
Table DSM Information List
Table Product Overview
Table DSM Bioresorbable Medical Material Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure DSM Bioresorbable Medical Material Business Region Distribution
Table Mitsui Chemicals Information List
Table Product Overview
Table Mitsui Chemicals Bioresorbable Medical Material Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure Mitsui Chemicals Bioresorbable Medical Material Business Region Distribution
Table PCAS Information List
Table Product Overview
Table PCAS Bioresorbable Medical Material Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure PCAS Bioresorbable Medical Material Business Region Distribution
Table Poly-Med Information List
Table Product Overview
Table Poly-Med Bioresorbable Medical Material Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure Poly-Med Bioresorbable Medical Material Business Region Distribution
Table KLS Martin Information List
Table Product Overview
Table KLS Martin Bioresorbable Medical Material Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure KLS Martin Bioresorbable Medical Material Business Region Distribution
Figure Global 2018-2025 Bioresorbable Medical Material Market Size (K MT) and Growth Rate Forecast
Figure Global 2018-2025 Bioresorbable Medical Material Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Bioresorbable Medical Material Sales Price (USD/MT) Forecast
Figure North America 2018-2025 Bioresorbable Medical Material Consumption Volume (K MT) and Growth Rate Forecast
Figure China 2018-2025 Bioresorbable Medical Material Consumption Volume (K MT) and Growth Rate Forecast
Figure Europe 2018-2025 Bioresorbable Medical Material Consumption Volume (K MT) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Bioresorbable Medical Material Consumption Volume (K MT) and Growth Rate Forecast
Figure Japan 2018-2025 Bioresorbable Medical Material Consumption Volume (K MT) and Growth Rate Forecast
Figure India 2018-2025 Bioresorbable Medical Material Consumption Volume (K MT) and Growth Rate Forecast
Table Global Sales Volume (K MT) of Bioresorbable Medical Material by Type 2018-2025
Table Global Consumption Volume (K MT) of Bioresorbable Medical Material by Application 2018-2025
Table Traders or Distributors with Contact Information of Bioresorbable Medical Material by Region
Key Market Players
The landscape consists of specialized polymer science companies, diversified chemical giants, and biomedical-focused manufacturers.
-
Leading Polymer & Material Science Specialists:
-
Evonik Industries AG – A global leader in biomedical polymers, offering a broad portfolio under its RESOMER® brand (PLA, PLGA, PCL, and copolymers).
-
Corbion N.V. – A major producer of high-purity lactic acid and polylactic acid (PLA), serving as a critical feedstock and material supplier.
-
Poly-Med, Inc. – A US-based developer and manufacturer of a wide array of bioresorbable polymers and medical devices.
-
DSM Biomedical (part of Darinor) – Provider of biomedical materials including bioresorbable polymers for various applications.
-
-
Diversified Chemical & Healthcare Companies:
-
Mitsui Chemicals, Inc. – Active in biomaterial development, including bioresorbable polymers.
-
Ashland Global Holdings Inc. – Supplies specialty polymers for pharmaceutical and medical applications.
-
Merck KGaA (through its MilliporeSigma division) – Supplier of high-purity bioresorbable polymers for R&D and GMP production.
-
-
Specialized Device & Fabrication Companies: KLS Martin Group (specializes in resorbable craniomaxillofacial implants), Osteotec Ltd., Bioretec Ltd., Gunze Limited.
4. Market Segmentation Analysis
4.1 By Polymer Type
-
Polylactic Acid (PLA) and its Stereoisomers (PLLA, PDLA): The largest volume segment. Known for good mechanical strength and tunable degradation (months to years). Widely used in orthopedic fixation, sutures, and meshes.
-
Polyglycolic Acid (PGA): Fast-degrading (weeks to months), high strength. Often used in sutures and combined in copolymers to modulate degradation rates.
-
Poly(lactic-co-glycolic acid) (PLGA): The most versatile and widely researched copolymer. Degradation rate is precisely tunable by altering the LA:GA ratio. Dominant in drug delivery systems (microspheres, implants) and tissue engineering scaffolds.
-
Polycaprolactone (PCL): Slow-degrading (years), highly elastic and biocompatible. Used in long-term implants, drug delivery devices, and as a component in hybrid scaffolds.
-
Polysaccharides & Other Natural Polymers: Includes Chitosan, Hyaluronic Acid, Alginate. Excel in biocompatibility and cell interaction. Growing segment for hydrogel-based drug delivery and soft tissue engineering.
4.2 By Application
-
Orthopedics: Largest application segment. Includes screws, pins, plates, anchors, and meniscal repair devices for sports medicine and trauma. Eliminates the need for a second removal surgery.
-
Drug Delivery: High-growth segment. Includes biodegradable microspheres, nanoparticles, implants, and injectable depots for controlled, long-term release of drugs (e.g., cancer therapeutics, hormones, antibiotics).
-
Tissue Engineering & Regeneration: Critical for 3D scaffolds that provide temporary structure for cell growth and are gradually replaced by natural tissue (e.g., bone grafts, cartilage, vascular grafts).
-
Sutures & Wound Care: Established application for synthetic (PGA, PLA) and natural (chitosan) resorbable sutures and hemostats.
4.3 By Form
-
Filaments & Fibers: For sutures, meshes, and 3D printing of scaffolds.
-
Pellets & Resins: Raw material for injection molding, extrusion, or machining into implants.
-
Microspheres/Nanoparticles: For drug delivery and as injectable scaffolds.
-
3D-Printed/Sintered Porous Scaffolds: Customized, complex architectures for tissue engineering.
